肖亚平;曾杰;焦琳娜;徐晓玉;
XIAO Ya-ping;ZENG Jie;JIAO Lin-na;XU Xiao-yu;College of Pharmaceutical Sciences & Chinese Medicine,Southwest University;Chongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine;Pharmacology of Chinese Materia Medica-the Key Discipline Constructed by the State Administration of Traditional Chinese Medicine;

• 1:西南大学药学院&中医药学院
• 2:重庆市高校中药新药筛选重点实验室
• 3:国家中医药管理局中药药理学重点建设学科

摘要(Abstract)：

有关补肾中药对于骨质疏松症的治疗及其信号通路调节作用的研究较多,但缺乏系统性的归纳总结。该文综合整理和分析了近10年来淫羊藿、骨碎补、蛇床子、杜仲、补骨脂、续断等经典补肾中药对骨质疏松症的治疗作用及其信号通路的调节作用。根据现有研究结果得出如下结论:(1)补肾中药主要通过BMP-Smads、Wnt/β-catenin、MAPK、PI3K/AKT等信号通路,促进成骨细胞的骨形成作用;通过OPG/RANKL/RANK、雌激素、CTSK等信号通路抑制破骨细胞的骨吸收作用,达到治疗骨质疏松症的目的。淫羊藿、骨碎补、蛇床子、补骨脂可通过上调BMP-Smads、Wnt/β-catenin信号通路中BMP-2、Smad1/5/8、Wnt3a及β-catenin等关键蛋白及基因的表达,促进成骨细胞的骨形成;淫羊藿、骨碎补、蛇床子、杜仲、补骨脂、续断通过介导OPG/RANKL/RANK信号通路,上调OPG和OPG/RANKL的表达,抑制破骨细胞的骨吸收。(2)补肾中药能通过多种途径防治骨质疏松症:淫羊藿中的淫羊藿苷、骨碎补中的柚皮苷、蛇床子中的蛇床子素、补骨脂中的补骨脂素既可以通过调控BMP-Smads、Wnt/β-catenin等信号通路促进骨形成,又可以活化OPG/RANKL/RANK、CTSK等信号通路抑制骨吸收。(3)补肾中药对防治骨质疏松症的信号通路的相互联系(crosstalk)和整体动物实验的研究有待进一步深入,有待阐明其多靶点和多途径的作用机制与综合调控作用。
The treatment effect and signaling pathway regulation effects of kidney-tonifying traditional Chinese medicine on osteoporosis have been widely studied,but there is no systematic summary currently.This review comprehensively collected and analyzed the traditional Chinese medicines on the treatment and signaling pathway regulation of osteoporosis in recent ten years,such as Epimedii Folium,Drynariae Rhizoma,Cnidii Fructus,Eucommiae Cortex,Psoraleae Fructus and Dipsaci Radix.Based on the existing findings,the following conclusions were obtained:(1) kidney-tonifying traditional Chinese medicine treated osteoporosis mainly through BMPSmads,Wnt/β-catenin,MAPK,PI3K/AKT signaling pathway to promote osteoblast bone formation and through OPG/RANKL/RANK,estrogen,CTSK signaling pathway to inhibit osteoclasts of bone resorption.Epimedii Folium,Drynariae Rhizoma,Cnidii Fructus and Psoraleae Fructus up-regulated the expression of key proteins and genes of BMP-Smads and Wnt/β-catenin signaling pathways to promote bone formation.Epimedii Folium,Drynariae Rhizoma,Cnidii Fructus,Eucommiae Cortex,Psoraleae Fructus and Dipsaci Radix inhibited the bone resorption by mediating the OPG/RANKL/RANK signaling pathway.(2) Kidney-tonifying traditional Chinese medicine prevented and treated osteoporosis through a variety of ways:icariin in Epimedii Folium,naringin in Drynariae Rhizoma,osthole in Cnidii Fructus and psoralen in Psoraleae Fructus can regulate BMP-Smads,Wnt/β-catenin signaling pathway to promote bone formation,but also activate OPG/RANKL/RANK,CTSK and other signaling pathways to inhibit bone resorption.(3)The crosstalk of the signaling pathways and the animal experiments of the traditional Chinese medicine on the prevention and treatment of osteoporosis as well as their multi-target mechanism and comprehensive regulation need further clarification.

关键词(KeyWords)： 补肾中药;骨质疏松症;信号通路;骨代谢;成骨细胞;破骨细胞
kidney-tonifying traditional Chinese medicine;osteoporosis;signaling pathways;bone metabolism;osteoblast;osteoclast

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目(81473549);; 教育部中央高校基本科研业务费项目(XDJK2017D158)

作者(Author): 肖亚平;曾杰;焦琳娜;徐晓玉;
XIAO Ya-ping;ZENG Jie;JIAO Lin-na;XU Xiao-yu;College of Pharmaceutical Sciences & Chinese Medicine,Southwest University;Chongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine;Pharmacology of Chinese Materia Medica-the Key Discipline Constructed by the State Administration of Traditional Chinese Medicine;

Email:

DOI: 10.19540/j.cnki.cjcmm.20171106.002

参考文献(References)：

• [1]Rachner T D,Khosla S,Hofbauer L C.Osteoporosis:now and the future[J].Lancet,2011,377(9773):1276.
• [2]An J,Yang H,Zhang Q,et al.Natural products for treatment of osteoporosis:the effects and mechanisms on promoting osteoblastmediated bone formation[J].Life Sci,2016,147:46.
• [3]Rosen V.BMP2 signaling in bone development and repair[J].Cytokine Growth Factor Rev,2009,20(5/6):475.
• [4]Canalis E,Economides A N,Gazzerro E.Bone morphogenetic proteins,their antagonists,and the skeleton[J].Endocr Rew,2013,24(2):218.
• [5]Miyazono K,Kamiya Y,Morikawa M.Bone morphogenetic protein receptors and signal transduction[J].J Biochem,2010,147(1):35.
• [6]Rodda S J,Mcmahon A P.Distinct roles for Hedgehog and canonical Wnt signaling in specification,differentiation and maintenance of osteoblast progenitors[J].Development,2006,133(16):3231.
• [7]Wang B,Jin H,Zhu M,et al.Chondrocyteβ-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model[J].Arthritis Rheumatol,2014,67(9):107.
• [8]Hee C Y,Young-Mi G,Jae-Wook O,et al.Osterix is regulated by Erk1/2 during osteoblast differentiation[J].Biochem Bioph Res Co,2011,415(3):472.
• [9]Wu C T,Lu T Y,Chan D C,et al.Effects of arsenic on osteoblast differentiation in vitro and on bone mineral density and microstructure in rats[J].Environ Health Persp,2014,122(6):559.
• [10]杨凤雪,杨冬珍,周建萍,等.应力刺激下ERK1/2信号通路对成牙骨质细胞OPG/RANKL表达的影响[J].解放军医学杂志,2014,39(12):941
• [11]Hu Y,Chan E,Wang S X,et al.Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation[J].Endocrinology,2003,144(5):2068.
• [12]Matsuguchi T,Chiba N,Bandow K,et al.JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation[J].J Bone Miner Res,2009,24(3):398.
• [13]Peng X D,Xu P Z,Chen M L,et al.Dwarfism,impaired skin development,skeletal muscle atrophy,delayed bone development,and impeded adipogenesis in mice lacking Akt1 and Akt2[J].Gene Dev,2003,17(11):1352.
• [14]Boyce B F,Xing L.Functions of RANKL/RANK/OPG in bone modeling and remodeling[J].Arch Biochem Biophys,2008,473(2):139.
• [15]Srivastava S,Toraldo G,Weitzmann M N,et al.Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand(RANKL)-induced JNK activation[J].J Biol Chem,2001,276(12):8836.
• [16]Nakamura T,Imai Y,Matsumoto T,et al.Estrogen prevents bone loss via estrogen receptorαand induction of fas ligand in osteoclasts[J].Cell,2007,130(5):811.
• [17]Vidal O,Kindblom L G,Ohlsson C.Expression and localization of estrogen receptor-beta in murine and human bone[J].J Bone Miner Res,1999,14(6):923.
• [18]Br9mme D,Lecaille F.Cathepsin K inhibitors for osteoporosis and potential off-target effects[J].Expert Opin Inv Drug,2009,18(5):585.
• [19]Xie F,Wu C F,Lai W P,et al.The osteoprotective effect of Herba Epimedii(HEP)extract in vivo and in vitro[J].Evidbased Compl Alt,2014,2(3):353.
• [20]Chen W F,Mok S K,Wang X L,et al.Total flavonoid fraction of the Herba Epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice[J].Brit J Nutr,2011,105(2):180.
• [21]Zhao B J,Wang J,Song J,et al.Beneficial effects of a flavonoid fraction of Herba Epimedii on bone metabolism in ovariectomized rats[J].Planta Med,2016,82(04):322.
• [22]杨丽,朱晓峰,王攀攀,等.淫羊藿水提取物对大鼠骨髓间充质干细胞骨向分化的影响及其机制[J].中草药,2013,44(22):3182.
• [23]梁广胜,陈伟才,殷嫦嫦,等.淫羊藿总黄酮对大鼠骨髓间充质干细胞成骨分化过程BMP-2/Run X2/OSX通路的影响[J].中国中西医结合杂志,2016,36(5):614.
• [24]Cao H,Ke Y,Zhang Y,et al.Icariin stimulates MC3T3-E1 cell proliferation and differentiation through,up-regulation of bone morphogenetic protein-2[J].Int J Mol Med,2012,29(3):435.
• [25]Zhou H,Wang S,Xue Y,et al.Regulation of the levels of smad1 and smad5 in MC3T3-E1 cells by icariin in vitro[J].Mol Med Rep,2014,9(2):590.
• [26]Liang W,Lin M,Li X,et al.Icariin promotes bone formation via the BMP-2/Smad4 signal transduction,pathway in the h FOB 1.19human osteoblastic cell line[J].Int J Mol Med,2012,30(4):889.
• [27]Hsieh T P,Sheu S Y,Sun J S,et al.Icariin isolated from epimedium pubescens regulates osteoblasts anabolism through BMP-2,SMAD4,and Cbfa1 expression[J].Phytomedicine,2010,17(6):414.
• [28]Fu S,Yang L,Hong H,et al.Wnt/β-catenin signaling is involved in the Icariin induced proliferation of bone marrow mesenchymal stem cells[J].J Traditional Chinese Med,2016,36(3):360.
• [29]曾建春,曾意荣,樊粤光,等.淫羊藿甙诱导MSCs向成骨细胞分化过程中对Wnt信号通路的影响[J].广州中医药大学学报,2014,31(4):607.
• [30]Wei Q,Zhang J,Hong G,et al.Icariin promotes osteogenic differentiation of rat bone marrow stromal cells by activating the ERα-Wnt/β-catenin signaling pathway[J].Biomed Pharmacother,2016,84:931.
• [31]Li X F,Xu H,Zhao Y J,et al.Icariin augments bone formation and reverses the phenotypes of osteoprotegerin-deficient mice through the activation of Wnt/β-catenin-BMP signaling[J].Evid-based Compl Alt,2013(9):1.
• [32]Xue L,Jiang Y,Han T,et al.Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu Maxim[J].J Ethnopharmacol,2016,192:370.
• [33]李红,周筠,张秀珍.p38MAPK途径在淫羊藿甙促成骨细胞分化中的作用[J].中华内分泌代谢杂志,2011,27(2):122.
• [34]Song L,Zhao J,Zhang X,et al.Icariin induces osteoblast proliferation,differentiation and mineralization through estrogen receptormediated ERK and JNK signal activation[J].Eur J Pharmacol,2013,714(1/3):15.
• [35]龚一昕,刘尚全,袁媛,等.淫羊藿次苷Ⅱ通过p38 MAPK调控成骨细胞护骨素表达的体外研究[J].安徽医科大学学报,2016,51(12):1790.
• [36]郭晓宇,葛宝丰,陈克明,等.淫羊藿苷促进大鼠骨髓基质细胞成骨性分化过程中对p-AKT及e NOS,i NOS表达量的影响[J].中国骨质疏松杂志,2013,19(9):897.
• [37]郭晓宇,李唯,陈克明,等.淫羊藿苷通过PI3K/AKT-e NOS信号途径促进大鼠骨髓基质细胞的成骨性分化[J].中国药理学通报,2013,29(7):966.
• [38]马小妮,葛宝丰,陈克明,等.淫羊藿苷通过OPG/RANKL信号途径调节骨吸收的机理研究[J].中国骨质疏松杂志,2013,19(1):1.
• [39]Wang F,Liu Z,Lin S,et al.Icariin enhances the healing of rapid palatal expansion induced root resorption in rats[J].Phytomedicine,2012,19(11):1035.
• [40]李伟娟,谢保平,石丽颖,等.从ERα/RANK通路探讨淫羊藿苷抑制破骨细胞分化作用[J].中国实验方剂学杂志,2017(7):121.
• [41]周建,陈克明,葛宝丰,等.淫羊藿苷抑制体外培养的大鼠股骨组织骨吸收活性[J].中国实验方剂学杂志,2013,19(24):201.
• [42]张怡元,林煜,冯尔宥,等.淫羊藿甙对体外钛微粒诱导破骨细胞骨吸收功能的影响[J].中国中医骨伤科杂志,2013(10):4.
• [43]Cai Y L,Zhang X C.Protective effect of Rhizoma Drynariae extract on osteoporosis in ovariectomized rat model[J].Trop J Pharm Res,2016,15(7):1447.
• [44]陈海啸,梁军波,伍海昭.骨碎补总黄酮对去卵巢大鼠腰椎松质骨骨形态计量学参数的影响[J].中医正骨,2011,23(4):18.
• [45]Hung T Y,Chen T L,Liao M H,et al.Drynaria fortunei J.Sm.promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults[J].J Ethnopharmacol,2010,131(1):70.
• [46]杨丽,朱晓峰,王攀攀,等.骨碎补水提液对大鼠MSCs骨向分化的影响及机制研究[J].中药材,2013,36(8):1287.
• [47]朱慧锋,王维佳,王珠美.骨碎补总黄酮对骨质疏松大鼠Smad1 Smad5基因表达的影响[J].中华中医药学刊,2010(1):200.
• [48]Zhu X F,Wang T C,Zhang R H,et al.Effects of total flavonoids in Drynaria fortunei(Kunze)J.Sm.on osteoblasts differentiation and expression of p38 protein kinase and BMP-2/Smads signaling after treatment by AGEs[J].Med Plant,2013,1(1):62.
• [49]丁佩惠,唐琪,陈莉丽.柚皮苷对小鼠成骨细胞MC3T3-E1增殖,分化和矿化的影响[J].中国中药杂志,2009,34(13):1712.
• [50]郭英,李佩芳,舒晓春,等.骨碎补总黄酮对骨髓间充质干细胞成骨分化过程中Wnt/β-catenin信号通路的影响[J].中华医学杂志,2012,92(32):2288.
• [51]汪甜,杨丽,张荣华.柚皮苷在促大鼠骨髓间充质干细胞骨向分化过程中对MAPK信号通路的影响[J].中国病理生理杂志,2012,28(5):769.
• [52]廖悦华,梁琼,王卓,等.中药骨碎补对去睾丸骨质疏松症动物模型的影响[J].中国骨质疏松杂志,2007,13(4):277.
• [53]刘康,吴风晴,吴连国,等.强骨胶囊对骨质疏松大鼠OPG/RANKL/RANK系统的影响[J].中华中医药杂志,2016(3):1071.
• [54]史晓林,李春雯,孙金谞,等.骨碎补总黄酮对去卵巢大鼠组织蛋白酶K的影响[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(4):285.
• [55]张巧艳,秦路平,黄宝康,等.蛇床子总香豆素对去卵巢大鼠骨质疏松症的作用[J].中国药学杂志,2003,38(2):101.
• [56]鲍君杰.蛇床子素防治去卵巢大鼠骨质疏松的实验研究[D].苏州:苏州大学,2005.
• [57]Tang D Z,Hou W,Zhou Q,et al.Osthole stimulates osteoblast differentiation and bone formation by activation ofβ-catenin-BMP signaling[J].J Bone Min Res,2010,25(6):1234.
• [58]Kuo P L,Hsu Y L,Chang C H,et al.Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells[J].J Pharmacol Exp Ther,2005,314(3):1290.
• [59]Hu H,Chen M,Dai G,et al.An inhibitory role of osthole in rat MSCs osteogenic differentiation and proliferation via Wnt/β-catenin and Erk1/2-MAPK pathways[J].Cell Physiol Biochem,2016,38(6):2375.
• [60]Zhai Y K,Pan Y L,Niu Y B,et al.The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro[J].Int J Endocrinol,2014,2014(9):921954.
• [61]周建,任雪梅,马小妮,等.蛇床子素对体外培养大鼠股骨组织吸收的抑制作用[J].中国骨伤,2015,28(9):832.
• [62]Zhang R,Liu Z G,Li C,et al.Du-Zhong(Eucommia ulmoides Oliv.)cortex extract prevent OVX-induced osteoporosis in rats[J].Bone,2009,45(3):553.
• [63]张贤,朱丽华,钱晓伟,等.杜仲醇提取物诱导骨髓间充质干细胞成骨分化中的Wnt信号途径[J].中国组织工程研究,2012,16(45):8520.
• [64]张立超,邓鸣涛,戴鹏,等.杜仲叶通过激活ERK及AKT磷酸化促进大鼠成骨细胞增殖的研究[J].中国骨质疏松杂志,2013,19(3):217.
• [65]陈林攀,邓鸣涛,杜川,等.杜仲叶提取物槲皮素通过激活ERK磷酸化促进BMSCs增殖的研究[J].时珍国医国药,2014(12):2845.
• [66]徐祥赫,刘钊,王虹,等.杜仲对MC3T3-E1成骨细胞及OPG/RANKL比值的影响[J].天津医科大学学报,2013,19(3):203.
• [67]Zhang R,Pan Y L,Hu S J,et al.Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro[J].J Ethnopharmacol,2014,155(1):104.
• [68]Leung P C,Siu W S.Herbal treatment for osteoporosis:a current review[J].J Tradit Complem,2013,3(2):82.
• [69]Tsai M H,Huang G S,Hung Y C,et al.Psoralea corylifolia extract ameliorates experimental osteoporosis in ovariectomized rats[J].Am J Chinese Med,2007,35(4):669.
• [70]Tang D,Wei H,Quan Z,et al.Psoralen stimulates osteoblast differentiation through activation of BMP signaling[J].Biochem Bioph Res Co,2011,405(2):256.
• [71]Weng Z B,Gao Q Q,Wang F,et al.Positive skeletal effect of two ingredients of Psoralea corylifolia L.on estrogen deficiencyinduced osteoporosis and the possible mechanisms of action[J].Mol Cell Endocrinol,2015,417:103.
• [72]田丹,刘钟杰,赵晓燕,等.补骨脂水提液对成骨细胞OPGRANKL mRNA表达的影响[J].中国兽医杂志,2011,47(12):12.
• [73]Niu Y B,Li Y H,Kong X H,et al.The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action[J].Osteoporosis Int,2012,23(11):2649
• [74]李家,林晓晟,王雅冰,等.续断皂苷Ⅵ对小鼠骨髓基质干细胞成骨分化的影响[J].口腔颌面修复学杂志,2017,18(1):28.
• [75]Niu Y,Li Y,Huang H,et al.AsperosaponinⅥ,a saponin component from Dipsacus asper Wall,induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway[J].Phytother Res,2011,25(11):1700.
• [76]陶益,陈西,任玉超,等.酒续断对骨质疏松型大鼠OPG/RANK/RANKL轴系统的调控研究[J].现代医药卫生,2016,32(8):1127.